Skip to main content
UniHealth

Doctor search

Xin Li, MD

Internal Medicine · Berkeley

NPI 1639442429

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Offices
5

Offices

5 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group

Looking this up.

Hospitals listed: Alta Bates Summit Medical Center · Alta Bates Summit Medical Center - Alta Bates Camp. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Li’s office to ask if they take your plan before you enroll.

California Medical Board record

Licence A134896 · Current

Licensed to practise in California · since 2015 · expires 2029-01-31 · Peking University Health Science Center.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Alta Bates Summit Medical CenterOakland, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 78% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 130.09 (87.72 to 172.46) · 109 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.227, Oct 2024 – Sep 2025
  • Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend it
    Overall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
See every measure and the patient survey for Alta Bates Summit Medical Center

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Alta Bates Summit Medical Center
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths130.09 (87.72 to 172.46) · 109 casesBetterJul 2022 – Jun 2024
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.274BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.227BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths1 (0.06 to 1.94) · 1,209 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.88 (0.6 to 1.16)No differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2 · 89 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.9 · 105 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.8 · 270 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths8.9 · 447 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths13.7 · 341 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths11.2 · 381 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.6 · 2,811 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.31) · 7,167 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.21 (0.02 to 0.4) · 7,659 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths2.93 (0.92 to 4.94) · 1,668 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.25 (0 to 2.75) · 580 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.67 (1.19 to 4.15) · 1,446 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths6.17 (0.33 to 12.02) · 633 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths8.11 (4.67 to 11.55) · 619 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.15 to 3.07) · 309 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.39 (0 to 0.96) · 6,085 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.8 · 217 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.724No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.425No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.716No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits12.7 · 416 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits19.6 · 606 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-30.4 · 359 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-31.8 · 555 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-14.4 · 358 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16 · 382 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.1 (3.2 to 8.2) · 25 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.8 (7.3 to 16) · 25 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits4.5 · 232 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.9 · 56 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20 · 152 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits14.8 (11.1 to 20) · 251 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1.2 (0.9 to 1.5) · 579 casesNo differentJan 2024 – Dec 2024

What patients said (535 patients answered, 18% of those asked)

Patient survey stars by topic at Alta Bates Summit Medical Center
Cleanliness4
Nurse communication3
Doctor communication4
Communication about medicines2
Discharge information3
Overall hospital rating4
Quietness3
Recommend hospital5
Share of patients giving the best answer at Alta Bates Summit Medical Center
Room was "always" clean73%
Nurses "always" communicated well75%
Doctors "always" communicated well81%
Staff "always" explained58%
Yes, staff "did" give patients this information86%
Yes, staff "did" give patients information about help after discharge87%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully79%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)75%
Staff "always" explained new medications73%
Nurses "always" explained things so they could understand69%
Nurses "always" listened carefully72%
Nurses "always" treated them with courtesy and respect85%
"Always" quiet at night54%
"YES", patients would definitely recommend the hospital78%
Staff "always" explained possible side effects43%
Yes, staff "did" give patients information about possible symptoms86%
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp

Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Alta Bates Summit Medical Center - Alta Bates Camp
Clostridium Difficile (C.Diff)Infections0.298BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.18 (0.16 to 2.2) · 730 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.87 (0.51 to 1.23)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths188.12 (132.31 to 243.94) · 50 casesNo differentJul 2022 – Jun 2024
Death rate for COPD patientsComplications and deaths6.8 · 50 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths10.8 · 41 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.4 · 189 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths12.6 · 184 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 103 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.9 · 1,585 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.18 (0 to 0.4) · 3,929 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.31 (0.11 to 0.51) · 3,954 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.15 (0.95 to 5.36) · 754 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.62 (0 to 3.33) · 325 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.99 (0.39 to 3.59) · 717 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths10.85 (2.27 to 19.44) · 326 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths4.79 (1.08 to 8.49) · 302 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.68 (0.19 to 3.18) · 184 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.17 (0 to 0.88) · 3,240 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.4 · 161 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.207No differentOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.48No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.785No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits19.4 · 243 casesNoneJul 2023 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-58.2 · 194 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-12.3 · 177 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.8 · 209 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.4 (3.8 to 7.5) · 215 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits12.2 (9.4 to 15.5) · 215 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits4.8 · 150 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.2 · 81 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.4 (10 to 18.1) · 315 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.8 (0.6 to 1.2) · 137 casesNo differentJan 2024 – Dec 2024

What patients said (449 patients answered, 15% of those asked)

Patient survey stars by topic at Alta Bates Summit Medical Center - Alta Bates Camp
Cleanliness2
Nurse communication2
Doctor communication2
Communication about medicines2
Discharge information2
Overall hospital rating2
Quietness2
Recommend hospital3
Share of patients giving the best answer at Alta Bates Summit Medical Center - Alta Bates Camp
Room was "always" clean62%
Nurses "always" communicated well72%
Doctors "always" communicated well75%
Staff "always" explained53%
Yes, staff "did" give patients this information82%
Yes, staff "did" give patients information about help after discharge82%
Doctors "always" explained things so they could understand68%
Doctors "always" listened carefully73%
Doctors "always" treated them with courtesy and respect83%
Patients who gave a rating of "9" or "10" (high)58%
Staff "always" explained new medications67%
Nurses "always" explained things so they could understand67%
Nurses "always" listened carefully66%
Nurses "always" treated them with courtesy and respect81%
"Always" quiet at night49%
"YES", patients would definitely recommend the hospital67%
Staff "always" explained possible side effects38%
Yes, staff "did" give patients information about possible symptoms83%

Original Medicare doctor bills

$119,447

Medicare paid this office $119,447 for 344 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Long return visit (40+ min)106$41,879$125
Return visit (30+ min)199$29,597$78
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes90$27,623$105
New patient visit (60+ min)45$7,297$162
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's190$6,205$15
See all 7 services
Every Original Medicare service billed
Long return visit (40+ min)106$41,879$125
Return visit (30+ min)199$29,597$78
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes90$27,623$105
New patient visit (60+ min)45$7,297$162
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's190$6,205$15
Initial hospital care with moderate level of medical decision making at least 75 minutes28$4,310$154
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes12$980$61

Who their Medicare patients are

344 Original Medicare patients in 2024. Average age 74 · Under 65 10% · 85 and older 14% · Women 66% · Also on Medicaid 38% · Health risk score 1.77. Above the middle of the specialty; the typical internal medicine clinician is at 1.76.

Conditions among them: High blood pressure 73% · Cancer 57% · Chronic kidney disease 30% · Diabetes 29% · Depression 22% · Coronary heart disease 19% · Heart failure 19% · COPD 17% · Atrial fibrillation 15% · Dementia 8% · Stroke 7%.

The office billed $503,409, Medicare allowed $156,194 and paid $119,447; for 1,501 services of 13 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20243441,501741.77$503,409$119,447
2023275975741.98$412,882$101,353
20222761,041742.12$426,185$105,996
20213221,281742.34$495,913$129,772
20202621,037752.61$379,286$87,354
2019227820743.04$292,604$64,995
201873174732.15$58,530$14,156

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 7 services

Original Medicare services billed in 2023
Long return visit (40+ min)88$37,622$124
Return visit (30+ min)153$29,398$80
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes75$21,102$108
New patient visit (60+ min)31$4,738$153
Initial hospital care with moderate level of medical decision making at least 75 minutes25$3,934$157
New patient visit (45+ min)13$1,570$121
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes11$1,436$72

2022: 7 services

Original Medicare services billed in 2022
Long return visit (40+ min)96$42,166$125
Return visit (30+ min)144$25,986$80
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes83$24,364$92
Initial hospital care with moderate level of medical decision making at least 75 minutes23$4,247$177
New patient visit (60+ min)22$3,638$165
New patient visit (45+ min)15$1,573$105
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes19$1,291$65

2021: 7 services

Original Medicare services billed in 2021
Long return visit (40+ min)77$46,928$128
Return visit (30+ min)170$36,312$84
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes118$29,799$93
New patient visit (45+ min)36$4,205$117
Initial hospital care with moderate level of medical decision making at least 75 minutes22$3,911$178
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes21$2,208$65
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes16$1,961$123

2020: 9 services

Original Medicare services billed in 2020
Return visit (30+ min)137$26,997$67
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes98$21,147$96
Long return visit (40+ min)51$18,793$103
Initial hospital care with moderate level of medical decision making at least 75 minutes34$5,986$171
New patient visit (45+ min)53$5,364$101
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes38$3,499$67
Telephone medical discussion with physician, 11-20 minutes29$1,646$46
Short return visit (20+ min)23$1,082$43
Telephone medical discussion with physician, 21-30 minutes12$1,020$73

2019: 6 services

Original Medicare services billed in 2019
Return visit (30+ min)110$25,830$67
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes85$19,776$92
Initial hospital care with moderate level of medical decision making at least 75 minutes37$7,082$169
New patient visit (45+ min)40$4,550$114
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes41$3,605$64
Short return visit (20+ min)41$2,579$42

2018: 4 services

Original Medicare services billed in 2018
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes25$5,744$93
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes17$1,746$65
Return visit (30+ min)18$1,537$70
Short return visit (20+ min)23$1,368$46

Medicaid work

$1,374 in 2024

Medicaid paid $1,374 for 313 billed services this clinician did in 2024, up to 22 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Long return visit (40+ min)180$704
Return visit (30+ min)133$670
Medicaid work by year
2024313222$1,374
202350217$297
202248116$615
202160116$643
2020188322$549
201917113$0
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Long return visit (40+ min)21$170
Return visit (30+ min)29$126

2022

Largest Medicaid services in 2022
Return visit (30+ min)48$615

2021

Largest Medicaid services in 2021
Return visit (30+ min)60$643

2020

Largest Medicaid services in 2020
Return visit (30+ min)148$270
COMPREHENSIVE METABOLIC PANEL20$161
Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count20$117

2019

Largest Medicaid services in 2019
Return visit (30+ min)17$0

Drugs they prescribed that Part D paid

$2,143,095

Pharmacies billed $2,143,095 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 3% of their Part D prescriptions (30 of 1,085) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%.

859 generic and 226 brand-name prescriptions · $2,143,095 in drug cost · 32 antibiotic prescriptions to 23 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Tagrisso34$554,965$16,322
Xtandi25$357,958$14,318
Kisqali22$317,511$14,432
Verzenio17$255,400$15,024
Eliquis40$28,851$721
See all 25 drugs
Every Part D drug this clinician prescribed
Tagrisso34$554,965$16,322
Xtandi25$357,958$14,318
Kisqali22$317,511$14,432
Verzenio17$255,400$15,024
Eliquis40$28,851$721
Xarelto14$15,538$1,110
Abiraterone Acetate19$4,952$261
Anastrozole181$3,470$19
Tamoxifen Citrate42$1,521$36
Tacrolimus11$1,438$131
Megestrol Acetate21$1,174$56
Letrozole43$973$23
Dexamethasone Sodium Phosphate19$945$50
Prochlorperazine Maleate73$731$10
Ondansetron56$728$13
Dexamethasone42$628$15
Potassium Chloride37$357$10
Loperamide16$303$19
Hydrocodone-Acetaminophen15$226$15
Pantoprazole20$139$7
Mirtazapine25$133$5
Acyclovir12$130$11
Hydroxyurea12$125$10
Prednisone23$97$4
Lactulose13$70$5

Year by year

Part D prescribing by year
20241,0851793% (30)21%$2,143,095
20238611493% (26)None$1,827,360
20228221485% (40)19%$833,253
20218991357% (58)None$886,816
20206841106% (40)21%$876,601
2019367703% (12)16%$190,230
20181344310% (13)10%$64,142
20171655913% (22)25%$102,882
2016734118% (13)36%$115,815
20151171310% (12)15%$21,498
201411022None20%$8,427
20136421NoneNone$3,881

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 16 drugs

Part D drugs prescribed in 2023
Tagrisso43$691,864$16,090
Xtandi17$225,863$13,286
Verzenio13$217,371$16,721
Eliquis58$47,455$818
Xarelto17$15,541$914
Anastrozole168$5,267$31
Tamoxifen Citrate69$2,571$37
Letrozole51$1,470$29
Ondansetron36$675$19
Prochlorperazine Maleate51$625$12
Potassium Chloride43$571$13
Dexamethasone16$351$22
Loperamide13$347$27
Hydrocodone-Acetaminophen11$295$27
Hydroxyurea11$165$15
Nystatin12$128$11

2022: 17 drugs

Part D drugs prescribed in 2022
Tagrisso36$536,629$14,906
Eliquis50$28,148$563
Xarelto21$17,036$811
Creon12$8,267$689
Anastrozole175$4,129$24
Tamoxifen Citrate67$2,133$32
Letrozole34$1,051$31
Ondansetron39$851$22
Hydrocodone-Acetaminophen24$684$29
Potassium Chloride28$572$20
Prochlorperazine Maleate47$542$12
Levofloxacin15$279$19
Dexamethasone17$268$16
Diphenoxylate-Atropine13$188$14
Gabapentin21$176$8
Prednisone24$117$5
Lorazepam13$42$3

2021: 22 drugs

Part D drugs prescribed in 2021
Tagrisso23$347,409$15,105
Ibrance19$272,667$14,351
Xarelto33$26,429$801
Creon17$19,150$1,126
Eliquis17$8,864$521
Anastrozole133$3,968$30
Tamoxifen Citrate39$1,697$44
Letrozole29$855$29
Potassium Chloride40$691$17
Hydrocodone-Acetaminophen35$538$15
Ondansetron32$513$16
Dexamethasone24$501$21
Prochlorperazine Maleate40$472$12
Pantoprazole31$236$8
Prednisone30$182$6
Acyclovir14$171$12
Nystatin16$150$9
Lidocaine Hcl Viscous15$141$9
Famotidine13$126$10
Gabapentin13$104$8
Furosemide13$27$2
Amlodipine Besylate11$17$2

2020: 15 drugs

Part D drugs prescribed in 2020
Tagrisso23$318,963$13,868
Ibrance21$277,320$13,206
Xarelto41$25,619$625
Anastrozole102$2,955$29
Tamoxifen Citrate25$1,833$73
Prochlorperazine Maleate61$778$13
Ondansetron41$559$14
Hydrocodone-Acetaminophen18$257$14
Levofloxacin17$179$11
Pantoprazole11$169$15
Dexamethasone13$169$13
Potassium Chloride12$124$10
Prednisone15$113$8
Lidocaine Hcl Viscous13$109$8
Lactulose12$85$7

2019: 9 drugs

Part D drugs prescribed in 2019
Xarelto14$9,213$658
Anastrozole58$1,874$32
Tamoxifen Citrate16$1,201$75
Ondansetron18$355$20
Acyclovir21$300$14
Dexamethasone17$292$17
Prochlorperazine Maleate16$225$14
Levofloxacin13$192$15
Lidocaine Hcl Viscous12$90$8

2018: 1 drug

Part D drugs prescribed in 2018
Anastrozole12$166$14

2017: 2 drugs

Part D drugs prescribed in 2017
Hydrocodone-Acetaminophen12$417$35
Anastrozole19$226$12

Money from drug and device companies

$157 in 2025

Industry payments by year
202533None$157
202411None$14
202311None$102
202268None$254
202167None$290
202033None$50
20191932None$678

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
AstraZeneca Pharmaceuticals LPLynparza$121
1 payment
  • Meals for Lynparza · 2025-05-01 · $121
Daiichi SankyoDatroway$20
1 payment
  • Meals for Datroway · 2025-08-19 · $20
Rigel PharmaceuticalsTavalisse$17
1 payment
  • Meals for Tavalisse · 2025-07-24 · $17
See all 3 published payments
Every published payment
Daiichi SankyoMeals · 2025-08-19Datroway$20
Rigel PharmaceuticalsMeals · 2025-07-24Tavalisse$17
AstraZeneca Pharmaceuticals LPMeals · 2025-05-01Lynparza$121
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $14

Payments by company in 2024
Bayer Healthcare PharmaceuticalsKerendia$14
1 payment
  • Meals for Kerendia · 2024-02-12 · $14

2023: $102

Payments by company in 2023
BeiGene USABrukinsa$102
1 payment
  • Meals for Brukinsa · 2023-06-30 · $102

2022: $254

Payments by company in 2022
GlaxoSmithKlineBlenrep$77
1 payment
  • Meals for Blenrep · 2022-08-27 · $77
PfizerIbrance$64
2 payments
  • Education for Ibrance · 2022-02-25 · $32
  • Education for Ibrance · 2022-02-09 · $32
SeagenPadcev$41
1 payment
  • Meals for Padcev · 2022-01-31 · $41
E.R. Squibb & Sons L.L.C.Opdivo$37
2 payments
  • Meals for Opdivo · 2022-11-29 · $18
  • Meals for Opdivo · 2022-07-13 · $18
AmgenLumakras$19
1 payment
  • Meals for Lumakras · 2022-10-28 · $19
Myriad Genetic LaboratoriesPrecisetumor$17
1 payment
  • Meals for Precisetumor · 2022-11-10 · $17

2021: $290

Payments by company in 2021
Daiichi SankyoEnhertu$113
1 payment
  • Meals for Enhertu · 2021-09-30 · $113
AmgenNone$100
1 payment
  • Education · 2021-11-21 · $100
PfizerInlyta$39
2 payments
  • Education for Inlyta · 2021-12-14 · $26
  • Education for Inlyta · 2021-03-24 · $13
SeagenAdcetris$13
1 payment
  • Education for Adcetris · 2021-09-08 · $13
Janssen BiotechErleada$13
1 payment
  • Meals for Erleada · 2021-03-12 · $13
Gilead SciencesNone$12
1 payment
  • Education · 2021-06-01 · $12

2020: $50

Payments by company in 2020
E.R. Squibb & Sons L.L.C.Opdivo$25
1 payment
  • Education for Opdivo · 2020-07-24 · $25
PfizerInlyta$13
1 payment
  • Education for Inlyta · 2020-08-20 · $13
Janssen BiotechErleada$12
1 payment
  • Meals for Erleada · 2020-01-29 · $12

2019: $678

Payments by company in 2019
AstraZeneca Pharmaceuticals LPImfinzi$117
4 payments
  • Meals for Imfinzi · 2019-12-04 · $76
  • Meals for Imfinzi · 2019-10-31 · $24
  • Meals for Tagrisso · 2019-07-27 · $16
  • Meals for Tagrisso · 2019-07-25 · $1
AmgenKyprolis$86
4 payments
  • Meals for Mvasi · 2019-10-10 · $20
  • Meals for Kanjinti · 2019-09-19 · $28
  • Meals for Kyprolis · 2019-08-15 · $18
  • Meals for Kyprolis · 2019-04-25 · $20
ExelixisCabometyx$73
1 payment
  • Meals for Cabometyx · 2019-05-08 · $73
PfizerBosulif$50
3 payments
  • Education for Braftovi · 2019-11-04 · $13
  • Meals for Bosulif · 2019-06-27 · $20
  • Meals for Ibrance · 2019-02-21 · $17
Bayer HealthCare PharmaceuticalsXofigo$42
2 payments
  • Meals for Vitrakvi · 2019-11-07 · $20
  • Meals for Xofigo · 2019-05-23 · $21
TesaroZejula$41
2 payments
  • Meals for Zejula · 2019-10-24 · $15
  • Meals for Zejula · 2019-05-30 · $26
Novartis PharmaceuticalsKisqali$40
2 payments
  • Meals for Tasigna · 2019-10-15 · $15
  • Meals for Kisqali · 2019-03-28 · $25
AMAG PharmaceuticalsFeraheme$30
2 payments
  • Education for Feraheme · 2019-08-01 · $13
  • Education for Feraheme · 2019-02-07 · $17
Takeda Pharmaceuticals U.S.A.Ninlaro$29
2 payments
  • Meals · 2019-02-28 · $16
  • Meals for Ninlaro · 2019-01-16 · $13
Daiichi SankyoInjectafer$23
1 payment
  • Meals for Injectafer · 2019-05-16 · $23
Clovis OncologyRubraca$21
1 payment
  • Meals for Rubraca · 2019-04-11 · $21
E.R. Squibb & Sons L.L.C.Opdivo$18
1 payment
  • Meals for Opdivo · 2019-03-07 · $18
CelgeneRevlimid$18
1 payment
  • Meals for Revlimid · 2019-09-05 · $18
Pharmacyclics LLC An AbbVieImbruvica$17
1 payment
  • Meals for Imbruvica · 2019-06-20 · $17
Agios PharmaceuticalsTibsovo$16
1 payment
  • Meals for Tibsovo · 2019-01-19 · $16
Boehringer Ingelheim PharmaceuticalsGilotrif$15
1 payment
  • Meals for Gilotrif · 2019-01-10 · $15
AbbVieVenclexta$15
1 payment
  • Meals for Venclexta · 2019-01-31 · $15
Merck Sharp & DohmeKeytruda$14
1 payment
  • Meals for Keytruda · 2019-07-11 · $14
Taiho OncologyLonsurf$13
1 payment
  • Meals for Lonsurf · 2019-07-26 · $13

Professional record

NPI
1639442429
Licence
CA A134896California A134896: Current · expires 2029-01-31
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Medical oncology (207RX0202X)
Mailing address
2001 Dwight Way, Berkeley, CA, 94704
NPI first listed
2012-02-10
NPI last updated
2018-10-10

This is when the NPI record was last certified, not a medical board exam.